Drug survival is not significantly different between biologics in patients with psoriasis vulgaris: a single‐centre database analysis

Abstract

There was no significant difference in drug survival, mean ∆PASI or Skindex-29 response at weeks 12 or 52 between the biologics or between the naive and non-naive groups. Treatment termination was due mostly to nonresponse. Sequential treatment with the available biologics can be effective.